Leslie M. Randall, MD
Assistant Professor of Clinical Obstetrics & Gynecology
University of California at Irvine Medical Center
101 The City Dr. South, Bldg 56
Rm 262
Orange,
CA
USA
92868
Biographical Sketch: Randall LM, et al. Markers of angiogenesis in high-risk, early-stage cervical cancer: A GOG study. Gynecol Oncol. 2009 Mar; 112(3):583-9. Randall LM, et al. Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a GOG phase II trial. Gynecol Oncol 2011"
Papers:
308 - Poster Session A
Initial investigation of combined single-photon emission computed tomography (SPECT) and magnetic resonance (MR) imaging of a human ovarian tumor xenograft using 123I-bevacizumab
383 - Poster Session B
Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer